Related references
Note: Only part of the references are listed.被撤回的出版物: Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy (Retracted article. See vol. 9, pg. 7078, 2013)
Priyambada Parhi et al.
ACTA BIOMATERIALIA (2011)
Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
Kazuo Maruyama
ADVANCED DRUG DELIVERY REVIEWS (2011)
Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy
Satya Prakash et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
R. Plummer et al.
BRITISH JOURNAL OF CANCER (2011)
Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives
Yiyun Cheng et al.
CHEMICAL SOCIETY REVIEWS (2011)
Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: Synthesis, antitumor efficiency in vivo and penetration in tumors
Dan Ding et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
Juan W. Valle et al.
INVESTIGATIONAL NEW DRUGS (2011)
Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system
Tatsuaki Tagami et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Advanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeutics
William B. Liechty et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin
Tatsuaki Tagami et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
Sonke Svenson et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
Xian-Zhu Yang et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Nanomaterials for cancer therapy and imaging
Ki Hyun Bae et al.
MOLECULES AND CELLS (2011)
Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution
Luigi Battaglia et al.
NANOMEDICINE (2011)
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
Han Jo Kim et al.
CANCER RESEARCH AND TREATMENT (2011)
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Christopher Lobo et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Phase I Study of NK012, a Novel SN-38-Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors
Tetsuya Hamaguchi et al.
CLINICAL CANCER RESEARCH (2010)
Enhanced antitumor efficacy by Paclitaxel-loaded Pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance
Zhang Wei et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles
Jinghua Duan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy
Keun Sang Oh et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: Preparation and antitumor activity in vivo
Zhenshu Zhu et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nanomedicine based approaches for the delivery of siRNA in cancer
B. Ozpolat et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
Sant P. Chawla et al.
MOLECULAR THERAPY (2010)
Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy
Twan Lammers et al.
NANO TODAY (2010)
Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer
Anekant Jain et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Cooperative nanomaterial system to sensitize, target, and treat tumors
Ji-Ho Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
David P. Nowotnik et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
V. Roy et al.
ANNALS OF ONCOLOGY (2009)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies
William C. Zamboni et al.
CLINICAL CANCER RESEARCH (2009)
Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors
Gerald Batist et al.
CLINICAL CANCER RESEARCH (2009)
Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants
Mario Bigioni et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Lipid Nanomedicines for Anticancer Drug Therapy
Ander Estella-Hermoso de Mendoza et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2009)
Pegylated Liposomal Doxorubicin Plus Docetaxel Significantly Improves Time to Progression Without Additive Cardiotoxicity Compared With Docetaxel Monotherapy in Patients With Advanced Breast Cancer Previously Treated With Neoadjuvant-Adjuvant Anthracycline Therapy: Results From a Randomized Phase III Study
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Advances of Cancer Therapy by Nanotechnology
Xu Wang et al.
CANCER RESEARCH AND TREATMENT (2009)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
Manuela Aleku et al.
CANCER RESEARCH (2008)
Clinical and Pharmacologic Study of the Novel Prodrug Delimotecan (MEN 4901/T-0128) in Patients with Solid Tumors
Stephan A. Veltkamp et al.
CLINICAL CANCER RESEARCH (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Jong-Ho Kim et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Emerging nanopharmaceuticals
Willie E. Bawarski et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
Keun Seok Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
D. -W. Kim et al.
ANNALS OF ONCOLOGY (2007)
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies
Jade Homsi et al.
CLINICAL CANCER RESEARCH (2007)
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma:: Combination therapy improves time to progression
Robert Z. Orlowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies
M. Kohandel et al.
PHYSICS IN MEDICINE AND BIOLOGY (2007)
Impact of prior thalidomide (T) therapy on the efficacy of pegylated liposomal doxorubicin (PLD) and bortezomib (B) in relapsed/refractory multiple myeloma (RRMM)
P. Sonneveld et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems
Twan Lammers et al.
JOURNAL OF CONTROLLED RELEASE (2007)
The present and future of nanotechnology in human health care
S. K. Sahoo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma
C. Bolling et al.
INVESTIGATIONAL NEW DRUGS (2006)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Nanomedicine transforms drug delivery
C Shaffer
DRUG DISCOVERY TODAY (2005)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Liposomal encapsulated anti-cancer drugs
RD Hofheinz et al.
ANTI-CANCER DRUGS (2005)
Nanomedicine: current status and future prospects
SM Moghimi et al.
FASEB JOURNAL (2005)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Y Matsumura et al.
ANNALS OF ONCOLOGY (2004)
Radiation improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts
CDL Davies et al.
CANCER RESEARCH (2004)
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer
AM Keller et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
P Sabbatini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Y Matsumura et al.
BRITISH JOURNAL OF CANCER (2004)
A phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Nanotech approaches to delivery and imaging drug
SK Sahoo et al.
DRUG DISCOVERY TODAY (2003)
Ligand-targeted liposomal anticancer drugs
P Sapra et al.
PROGRESS IN LIPID RESEARCH (2003)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
J Panyam et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Lymphatic metastasis in the absence of functional intratumor lymphatics
TP Padera et al.
SCIENCE (2002)
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma
L Harris et al.
CANCER (2002)
Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan
AN Gordon et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer
G Batist et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
